Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer. (Q37709099)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer. |
scientific article |
Statements
Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer (English)
VĂ©ronique Becette
Franck Assayag
Camille Benoist
Maud Kamal
Florence Lerebours
CĂ©line Callens
1 reference
1 reference
1 reference
1 reference
1 reference